Xenogeneic mesenchymal stem cell transplantation for mandibular defect regeneration

Area of Science:

• Tissue Engineering
• Immunology
• Regenerative Medicine

Background:

• Xenogeneic stem cell transplantation is crucial for tissue engineering but often encounters host immune rejection.
• This study investigates strategies to overcome immune rejection in xenogeneic transplantation by modulating host immunity.

Purpose of the Study:

• To evaluate if diminishing T-cell immunity can evade host immune rejection in xenogeneic stem cell transplantation.
• To assess the survival of donor cells and the host immune response in a rat mandibular defect model.

Main Methods:

• Pig bone marrow-derived mesenchymal stem cells (BM-MSCs) were transplanted into mandibular defects of immunocompetent and T cell-deficient athymic rats.
• Donor cell survival and host immune reactions were monitored using cell tracking and apoptosis assays.
• Bone regeneration was assessed by measuring bone volume fraction.

Main Results:

• Donor cell survival was comparable between athymic and immunocompetent rats by post-operative day 3-7, with low apoptosis.
• Host innate immune cells (neutrophils, macrophages) infiltrated MSC-treated sites, with delayed but strong infiltration in athymic rats.
• No significant difference in bone regeneration was observed between BM-MSC treated and control groups.

Conclusions:

• Even with diminished T-cell immunity, xenogeneic BM-MSC transplantation into critical-sized mandibular defects is challenged by host innate immunity.
• The host innate immune response compromises the regenerative efficacy of xenogeneic BM-MSCs in this model.